Using biomarkers to prioritise patients with stable angina pectoris for bypass surgery: Predicting risk does not necessarily translate to preventing it

BMJ (Online)

Volumn 340, Issue 7739, 2010, Pages 163-

  Terkelsen, Christian Juhl ^a   Vach, Werner ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER;

CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CORONARY ARTERY BYPASS SURGERY; COST EFFECTIVENESS ANALYSIS; EDITORIAL; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; STABLE ANGINA PECTORIS; ANGINA PECTORIS; BLOOD; CORONARY ARTERY BYPASS GRAFT; EMERGENCY HEALTH SERVICE; GLOMERULUS FILTRATION RATE; HOSPITAL ADMISSION; METHODOLOGY; NOTE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANGINA PECTORIS; BIOLOGICAL MARKERS; CORONARY ARTERY BYPASS; GLOMERULAR FILTRATION RATE; HUMANS; RISK ASSESSMENT; TRIAGE; WAITING LISTS;

EID: 76249115980     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b5414     Document Type: Editorial

References (12)

1. Hochman JS, Steg PG. Does preventive PCI work? N Engl J Med 2007;356:1572-4.[Free Full Text]
2. Seddon ME, French JK, Amos DJ, Ramanathan K, McLaughlin SC, White HD. Waiting times and prioritization for coronary artery bypass surgery in New Zealand. Heart 1999;81:586-92.[Abstract/Free Full Text]
3. Jackson NW, Doogue MP, Elliott JM. Priority points and cardiac events while waiting for coronary bypass surgery. Heart 1999;81:367-73. [Abstract/Free Full Text]
4. Henriksson M, Palmer S, Chen R, Damant J, Fitzpatrick N, Abrams K, et al. The cost effectiveness of using prognostic biomarkers to prioritise patients waiting for coronary artery surgery: decision analytical model. BMJ 2010;340:b5606.[Abstract/Free Full Text]
5. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu Cy. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.[Abstract/Free Full Text]
6. Hostetter TH. Chronic kidney disease predicts cardiovascular disease. N Engl J Med 2004;351:1344-6.[Free Full Text]
7. Anavekar NS, McMurray JJV, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351:1285-95.[Abstract/Free Full Text]
8. Martin RM, Gunnell D, Karsch KR, Frankel S. Mortality and morbidity surrounding coronary artery bypass surgery and the public presentation of risk. J Epidemiol Community Health 2002;56:430-1.[Free Full Text]
9. Anderson RJ, O'Brien M, Mawhinney S, Villanueva CB, Moritz TE, Sethi GK, et al. Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. Kidney Int 1999;55:1057-62.[CrossRef][Web of Science][Medline]
10. Ruilope LM, Zanchetti A, Julius S, Mcinnes GT, Segura J, Stolt P, et al. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial. J Hypertens 2007;25:1473-9.[CrossRef][Web of Science] [Medline]
11. Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harringthon RA, Califf RM, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002;106:974-80. [Abstract/Free Full Text]
12. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MSV, et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009;119:2408-16.[Abstract/Free Full Text]